Abstract
BackgroundMaternal diabetes alters gene expression leading to neural tube defects (NTDs) in the developing brain. The mechanistic pathways that deregulate the gene expression remain unknown. It is hypothesized that exposure of neural stem cells (NSCs) to high glucose/hyperglycemia results in activation of epigenetic mechanisms which alter gene expression and cell fate during brain development.Methods and FindingsNSCs were isolated from normal pregnancy and streptozotocin induced-diabetic pregnancy and cultured in physiological glucose. In order to examine hyperglycemia induced epigenetic changes in NSCs, chromatin reorganization, global histone status at lysine 9 residue of histone H3 (acetylation and trimethylation) and global DNA methylation were examined and found to be altered by hyperglycemia. In NSCs, hyperglycemia increased the expression of Dcx (Doublecortin) and Pafah1b1 (Platelet activating factor acetyl hydrolase, isoform 1b, subunit 1) proteins concomitant with decreased expression of four microRNAs (mmu-miR-200a, mmu-miR-200b, mmu-miR-466a-3p and mmu-miR-466 d-3p) predicted to target these genes. Knockdown of specific microRNAs in NSCs resulted in increased expression of Dcx and Pafah1b1 proteins confirming target prediction and altered NSC fate by increasing the expression of neuronal and glial lineage markers.Conclusion/InterpretationThis study revealed that hyperglycemia alters the epigenetic mechanisms in NSCs, resulting in altered expression of some development control genes which may form the basis for the NTDs. Since epigenetic changes are reversible, they may be valuable therapeutic targets in order to improve fetal outcomes in diabetic pregnancy.
Highlights
Diabetes during pregnancy is a well-known risk factor for congenital anomalies in various organ systems including the nervous system [1,2,3]
We show for the first time that hyperglycemia alters epigenetic mechanisms in neural stem cells (NSCs) which may form the basis for neural tube defects observed in diabetic pregnancy
Chromatin Reorganization in NSCs Exposed to Hyperglycemia
Summary
Diabetes during pregnancy is a well-known risk factor for congenital anomalies in various organ systems including the nervous system [1,2,3]. It has been shown that maternal diabetes alters the expression of several genes involved in neurulation [9,10], proliferation and cell fate specification [11] of NSCs which may form the basis for neural tube defects. NSCs differentiate into neuronal and glial cell types in a sequential fashion. Cell fate specification of NSC is determined by extracellular signals, transcription factors and intracellular programmes such as the epigenetic regulation of gene expression [12,13,14]. Maternal diabetes alters gene expression leading to neural tube defects (NTDs) in the developing brain. It is hypothesized that exposure of neural stem cells (NSCs) to high glucose/hyperglycemia results in activation of epigenetic mechanisms which alter gene expression and cell fate during brain development
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
